InnovAge (NASDAQ:INNV) Issues Earnings Results

InnovAge (NASDAQ:INNVGet Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.10) earnings per share for the quarter, Zacks reports. InnovAge had a negative return on equity of 5.68% and a negative net margin of 2.03%. InnovAge updated its FY 2025 guidance to EPS.

InnovAge Stock Performance

INNV traded up $0.16 during trading on Tuesday, reaching $3.69. 63,004 shares of the company were exchanged, compared to its average volume of 57,832. InnovAge has a 52 week low of $3.49 and a 52 week high of $6.69. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.27. The firm has a 50 day moving average of $4.09 and a 200 day moving average of $5.26. The stock has a market cap of $499.85 million, a P/E ratio of -30.75 and a beta of 0.37.

Analyst Ratings Changes

INNV has been the subject of a number of research reports. JPMorgan Chase & Co. reiterated an “underweight” rating and issued a $5.00 price target on shares of InnovAge in a research note on Tuesday, December 17th. KeyCorp initiated coverage on InnovAge in a report on Friday, October 11th. They issued a “sector weight” rating for the company.

Get Our Latest Research Report on InnovAge

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Further Reading

Earnings History for InnovAge (NASDAQ:INNV)

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.